AMERISAFE End Period Cash Flow vs Capital Expenditures Analysis
AMSF Stock | USD 51.63 0.51 0.98% |
AMERISAFE financial indicator trend analysis is way more than just evaluating AMERISAFE prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AMERISAFE is a good investment. Please check the relationship between AMERISAFE End Period Cash Flow and its Capital Expenditures accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.
End Period Cash Flow vs Capital Expenditures
End Period Cash Flow vs Capital Expenditures Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AMERISAFE End Period Cash Flow account and Capital Expenditures. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between AMERISAFE's End Period Cash Flow and Capital Expenditures is -0.31. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of AMERISAFE, assuming nothing else is changed. The correlation between historical values of AMERISAFE's End Period Cash Flow and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of AMERISAFE are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of End Period Cash Flow i.e., AMERISAFE's End Period Cash Flow and Capital Expenditures go up and down completely randomly.
Correlation Coefficient | -0.31 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
End Period Cash Flow
Capital Expenditures
Capital Expenditures are funds used by AMERISAFE to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of AMERISAFE operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most indicators from AMERISAFE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AMERISAFE current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.At this time, AMERISAFE's Enterprise Value Multiple is most likely to increase significantly in the upcoming years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 265.2M | 244.1M | 306.9M | 291.0M | Total Revenue | 316.0M | 294.7M | 306.9M | 329.6M |
AMERISAFE fundamental ratios Correlations
Click cells to compare fundamentals
AMERISAFE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AMERISAFE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.5B | 1.5B | 1.4B | 1.3B | 1.2B | 1.2B | |
Total Stockholder Equity | 430.2M | 438.8M | 399.3M | 317.4M | 292.5M | 299.4M | |
Property Plant And Equipment Net | 6.3M | 6.5M | 6.7M | 7.3M | 6.4M | 7.2M | |
Net Debt | (43.3M) | (61.3M) | (70.3M) | (61.1M) | (38.7M) | (40.6M) | |
Retained Earnings | 227.2M | 224.6M | 190.5M | 145.5M | 114.3M | 152.8M | |
Non Current Assets Total | 1.1B | 1.1B | 1.0B | 896.3M | 1.2B | 1.3B | |
Non Currrent Assets Other | (1.1B) | (1.1B) | (1.0B) | (40.2M) | (191.5M) | (201.0M) | |
Other Assets | 63.9M | 51.3M | 57.1M | (281.0M) | (589.9M) | (560.4M) | |
Cash And Short Term Investments | 43.8M | 61.8M | 70.7M | 61.5M | 355.7M | 373.5M | |
Net Receivables | 253.9M | 262.6M | 255.7M | 257.3M | 272.9M | 252.8M | |
Common Stock Shares Outstanding | 19.3M | 19.4M | 19.4M | 19.3M | 19.2M | 16.9M | |
Short Term Investments | 497.7M | 460.2M | 399.2M | 335.2M | 317.1M | 346.9M | |
Liabilities And Stockholders Equity | 1.5B | 1.5B | 1.4B | 1.3B | 1.2B | 1.2B | |
Non Current Liabilities Total | 1.1B | 1.0B | 997.0M | 38.1M | 936.7M | 585.5M | |
Other Stockholder Equity | 190.6M | 192.9M | 195.1M | 185.5M | 185.1M | 164.0M | |
Total Liab | 40.1M | 38.9M | 37.9M | 951.8M | 936.7M | 811.6M | |
Property Plant And Equipment Gross | 6.1M | 6.3M | 6.3M | 6.5M | 7.5M | 7.1M | |
Total Current Assets | 297.7M | 324.3M | 326.4M | 654.0M | 628.6M | 433.5M | |
Cash | 43.8M | 61.8M | 70.7M | 61.5M | 38.7M | 65.1M | |
Other Current Liab | (40.1M) | (417K) | (44.3M) | (39.5M) | 544.0M | 571.2M | |
Total Current Liabilities | 40.1M | 38.9M | 37.9M | 38.1M | 544.0M | 571.2M | |
Other Liab | 642.5M | 902.8M | 882.3M | 798.8M | 918.6M | 468.7M | |
Accounts Payable | 40.1M | 38.9M | 37.9M | 38.1M | 43.8M | 32.9M | |
Long Term Debt | 37.9M | 43.4M | 42.9M | 48.8M | 56.1M | 38.6M | |
Accumulated Other Comprehensive Income | 12.2M | 21.0M | 13.5M | (13.8M) | (7.2M) | (6.8M) | |
Property Plant Equipment | 6.3M | 6.2M | 6.5M | 7.2M | 8.3M | 7.2M | |
Other Current Assets | 345.2M | 397.9M | 379.9M | 276.9M | 271.6M | 298.6M | |
Net Tangible Assets | 430.2M | 438.8M | 399.3M | 317.4M | 285.7M | 328.5M | |
Good Will | 1.1B | 1.1B | 987.8M | 816.9M | 939.4M | 986.4M | |
Retained Earnings Total Equity | 227.2M | 224.6M | 190.5M | 145.5M | 131.0M | 179.9M | |
Long Term Debt Total | 37.9M | 43.4M | 42.9M | 48.8M | 56.1M | 43.7M | |
Capital Surpluse | 213.0M | 215.3M | 217.5M | 220.3M | 253.3M | 226.0M | |
Inventory | (345.2M) | (397.9M) | (379.9M) | 68.2M | (271.6M) | (258.0M) | |
Long Term Investments | 1.1B | 1.1B | 1.0B | 897.4M | 857.8M | 1.1B | |
Non Current Liabilities Other | 1.0B | 988.2M | 960.5M | 903.0M | 1.0B | 1.1B | |
Intangible Assets | 19.0M | 17.8M | 17.1M | 17.4M | 18.0M | 19.1M |
Currently Active Assets on Macroaxis
When determining whether AMERISAFE is a strong investment it is important to analyze AMERISAFE's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AMERISAFE's future performance. For an informed investment choice regarding AMERISAFE Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AMERISAFE. If investors know AMERISAFE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AMERISAFE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.443 | Dividend Share 1.45 | Earnings Share 3.21 | Revenue Per Share 16.5 | Quarterly Revenue Growth 0.083 |
The market value of AMERISAFE is measured differently than its book value, which is the value of AMERISAFE that is recorded on the company's balance sheet. Investors also form their own opinion of AMERISAFE's value that differs from its market value or its book value, called intrinsic value, which is AMERISAFE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AMERISAFE's market value can be influenced by many factors that don't directly affect AMERISAFE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AMERISAFE's value and its price as these two are different measures arrived at by different means. Investors typically determine if AMERISAFE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AMERISAFE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.